longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Electra Therapeutics

ETRA

10.0505.90% ( -0.630 )
Trading: Oct 2, 13:53:01 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • 12 Health Care Stocks Moving In Wednesday's Pre-Market Session

    benzinga_article·2 days ago, 12:05 PM
    ALVR0.00%CNTB-4.23%
  • OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake

    TradingView·Sep 25 at 09:36 PM
    ETRA-5.90%
  • OrbiMed Advisors acquires 1,333,333 Electra Therapeutics shares for USD 20 million

    PUBT·Sep 23 at 09:30 PM
    ETRA-5.90%
  • Electra Therapeutics files Form 3 as Westlake BioPartners Fund I reports beneficial ownership

    PUBT·Sep 22 at 01:01 AM
    ETRA-5.90%
  • Electra Therapeutics adopts amended, restated bylaws effective at IPO close

    PUBT·Sep 21 at 08:01 PM
    ETRA-5.90%
  • HBM Healthcare Investments says Electra Therapeutics IPO raises USD 350 million

    PUBT·Sep 21 at 04:45 AM
    ETRA-5.90%
  • US IPO Weekly Winners & Losers

    RenaissanceCapital·Sep 20 at 04:01 PM
    - The US IPO market faced headwinds this week as the 10 year Treasury yield hit its highest level since 2007 and the Fed raised interest rates. - Despite rocky conditions and Holtec Nuclear postponing its $825 million IPO, three sizable deals priced and the IPO Index outperformed the S&P 500 by gaining 0.5%. - The IPO Index finalized its Q3 rebalance by adding nine companies, including SpaceX, ahead of upcoming launches.
    TEM+0.16%VG+3.48%
  • US IPO Weekly Recap: Data center developer Nscale files, while Holtec Nuclear postpones IPO

    RenaissanceCapital·Sep 18 at 11:30 PM
    - The US IPO market featured three priced IPOs and two SPACs, alongside five new IPO and three SPAC filings. - Holtec Nuclear postponed its $825 million IPO, while Nscale filed for a potential multibillion-dollar offering. - Electra Therapeutics, Orion180 Insurance Group, and American Savings Bank successfully priced their offerings, raising $350 million, $240 million, and $129 million respectively.
    ETRA-5.90%LEDRU+0.10%
  • Antibody therapy developer Electra upsizes IPO seeking nearly $350M

    businessinsider·Sep 18 at 02:45 PM
    ETRA-5.90%